CLSI M51-A (R2018)
Method for Antifungal Disk Diffusion Susceptibility Testing of Filamentous Fungi; Approved Guideline, M51Astandard by Clinical and Laboratory Standards Institute, 01/01/2010
CLSI MM07-A2 (R2018)
Fluorescence In Situ Hybridization Methods for Clinical Laboratories; Approved Guideline--Second Edition, MM07A2Estandard by Clinical and Laboratory Standards Institute, 08/30/2013
CLSI MM19-A
Establishing Molecular Testing in Clinical Laboratory Environments; Proposed Guideline, MM19AEstandard by Clinical and Laboratory Standards Institute, 11/01/2011
CLSI AUTO11-A2
IT Security of In Vitro Diagnostic Instruments and Software Systems; Proposed Standard, AUTO11A2Estandard by Clinical and Laboratory Standards Institute, 10/01/2014
CLSI M48-A
Laboratory Detection and Identification of Mycobacteria; Approved Guideline, M48AEstandard by Clinical and Laboratory Standards Institute, 01/01/2008
CLSI H02-A5
Procedures for the Erythrocyte Sedimentation Rate Test; Approved Standard - Fifth Edition, H02A5standard by Clinical and Laboratory Standards Institute, 05/01/2011
CLSI POCT04-Ed3
Essential Tools for Implementation and Management of a Point-of-Care Testing Program, POCT04Ed3Estandard by Clinical and Laboratory Standards Institute, 06/01/2016
CLSI M54-A
Principles and Procedures for Detection of Fungi in Clinical Specimens - Direct Examination and Culture; Approved Guideline, M54Astandard by Clinical and Laboratory Standards Institute, 10/01/2012
CLSI NBS05-A
Newborn Screening for Cystic Fibrosis; Approved Guideline (Formerly I/LA35-A), NBS05AEstandard by Clinical and Laboratory Standards Institute,
CLSI NBS03-A
Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline (formerly I/LA31-A), NBS03AEstandard by Clinical and Laboratory Standards Institute,